Anne Rosén

Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings

Keith Zucker, Anne Rosén, Alexandra Tsaroucha et al. · Transplant Immunology · 1997 · 229 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Serial Ten‐Year Follow‐Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure

Kazuo Mizutani, Paul I. Terasaki, Anne Rosén et al. · American Journal of Transplantation · 2005 · 222 citations · Full text

Life Sciences, Immunology, Nephrology +16

A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1

Gaetano Ciancio, George W. Burke, Jeffrey J. Gaynor et al. · Transplantation · 2005 · 218 citations

Pharmacy, Immunology, Nephrology +17

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. Ii. Survival, function, and protocol compliance at 1 year

Gaetano Ciancio, George W. Burke, Jeffrey J. Gaynor et al. · Transplantation · 2004 · 160 citations

Medicine, Nephrology, Surgery +17

The Importance of Anti-HLA-Specific Antibody Strength in Monitoring Kidney Transplant Patients

K. Mizutani, Paul I. Terasaki, E Hamdani et al. · American Journal of Transplantation · 2007 · 130 citations

Life Sciences, Immunology, Nephrology +14